Industry / United Kingdom

GSK Reforms Pricing Structures

March 2008 | Industry News

In what could usher in a paradigm shift in the drug sector, UK-based pharmaceutical giant

To read the full article, please sign in or take a free trial.

Related Insight Articles

First OTC Treatment Of Benign Prostatic Hyperplasia Available

Industry / United Kingdom The MHRA has revealed that the UK will be the first country in the world to offer patients an over-the-counter (OTC) benign prostatic hyperplasia (BHP) treatment, highlighting the country's status as...

December 2009

GSK To Provide Labs For 2012 Athlete Drug Testing

Industry / United Kingdom UK-based drugmaker GlaxoSmithKline (GSK) has been selected as a laboratory services provider to enable Kings College London to operate a World Anti-Doping Agency (WADA)-accredited laboratory at the London...

December 2009

Innovation Pass Pilot Launched

Industry / United Kingdom An pilot scheme for the 'Innovation Pass', which would allow earlier access to innovative medicines targeting rare diseases that have not been appraised by the National Institute for Health and Clinical...

December 2009

GW Pharma: Profitable In 2009

Industry / United Kingdom Cannabis medicine specialist GW Pharma has announced full-year profit of US$2.5mn. This strengthened financial position (compared with the US$13.6mn loss the company recorded in 2008) comes as the result...

November 2009

GBP1mn Per Hour Spent Treating Diabetes

Industry / United Kingdom Treating diabetes mellitus costs the UK's National Health Service (NHS) around GBP9bn (US$15.5bn) a year - around GBP1mn (US$1.7mn) per hour - according to a report from charity Diabetes UK. With both...

October 2008